Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill Anderson

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Circulation|August 26, 2009
Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure populationWayne C Levy, Kerry L Lee, Anne S Hellkamp, et al.
Journal of the American College of Cardiology|July 25, 2020
Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFTJeanne E Poole, Brian Olshansky, Daniel B Mark, et al.
American Heart Journal|April 6, 2010
Quality of life effects of automatic external defibrillators in the home: results from the Home Automatic External Defibrillator Trial (HAT)Daniel B Mark, Kevin J Anstrom, Steven E McNulty, et al.
Journal of the American College of Cardiology|August 9, 2008
No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)Joseph A Blatt, Jeanne E Poole, George W Johnson, et al.
The New England Journal of Medicine|January 22, 2005
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failureGust H Bardy, Kerry L Lee, Daniel B Mark, et al.
The New England Journal of Medicine|September 5, 2008
Prognostic importance of defibrillator shocks in patients with heart failureJeanne E Poole, George W Johnson, Anne S Hellkamp, et al.
Circulation|November 18, 2009
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trialDouglas L Packer, Jordan M Prutkin, Anne S Hellkamp, et al.
The New England Journal of Medicine|April 3, 2008
Home use of automated external defibrillators for sudden cardiac arrestGust H Bardy, Kerry L Lee, Daniel B Mark, et al.
American Heart Journal|February 26, 2008
Rationale and design of the Home Automatic External Defibrillator Trial (HAT)Gust H Bardy, Kerry L Lee, Daniel B Mark, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 27, 2022
Three-Month Symptom Profiles Among Symptomatic Adults With Positive and Negative Severe Acute Respiratory Syndrome Coronavirus 2 Tests: A Prospective Cohort Study From the INSPIRE GroupErica S Spatz, Michael Gottlieb, Lauren E Wisk, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Circulation|August 26, 2009
Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure populationWayne C Levy, Kerry L Lee, Anne S Hellkamp, et al.
Journal of the American College of Cardiology|July 25, 2020
Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFTJeanne E Poole, Brian Olshansky, Daniel B Mark, et al.
American Heart Journal|April 6, 2010
Quality of life effects of automatic external defibrillators in the home: results from the Home Automatic External Defibrillator Trial (HAT)Daniel B Mark, Kevin J Anstrom, Steven E McNulty, et al.
Journal of the American College of Cardiology|August 9, 2008
No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)Joseph A Blatt, Jeanne E Poole, George W Johnson, et al.
The New England Journal of Medicine|January 22, 2005
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failureGust H Bardy, Kerry L Lee, Daniel B Mark, et al.
The New England Journal of Medicine|September 5, 2008
Prognostic importance of defibrillator shocks in patients with heart failureJeanne E Poole, George W Johnson, Anne S Hellkamp, et al.
Circulation|November 18, 2009
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trialDouglas L Packer, Jordan M Prutkin, Anne S Hellkamp, et al.
The New England Journal of Medicine|April 3, 2008
Home use of automated external defibrillators for sudden cardiac arrestGust H Bardy, Kerry L Lee, Daniel B Mark, et al.
American Heart Journal|February 26, 2008
Rationale and design of the Home Automatic External Defibrillator Trial (HAT)Gust H Bardy, Kerry L Lee, Daniel B Mark, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 27, 2022
Three-Month Symptom Profiles Among Symptomatic Adults With Positive and Negative Severe Acute Respiratory Syndrome Coronavirus 2 Tests: A Prospective Cohort Study From the INSPIRE GroupErica S Spatz, Michael Gottlieb, Lauren E Wisk, et al.
Pageof 7